Pluton Biosciences
St. Louis, US · Delaware corporation · 11 known investors
Pluton Biosciences develops novel microbes and scales them to industrial volumes at commodity pricing for agriculture and climate applications. The company applies microbial discovery and genomics to create products aimed at sustainable agriculture and environmental protection.
AgTechBiotechClimate TechDeep Tech
Founders & leadership
BG
Barry GoldmanCo-founder
EG
Elizabeth GallegosChief Executive Officer
JS
Jerry SteinerExecutive Chair
CW
Charlie WalchNamed on SEC filing
GS
Glendon SchusterNamed on SEC filing
Investors · 11
First In Ventures✓ verifiedMiddletown · $50K – $200K
Illumina Ventures✓ verifiedFoster City
Radicle Growth✓ verifiedSan Diego
Better Ventures✓ verifiedOakland
Fall Line Capital✓ verifiedSan Francisco
Grantham Foundation✓ verifiedBoston
RA Capital✓ verifiedBoston
The Yield Lab✓ verifiedSingapore · $48K – $12M
.png)
Better Ventures Central LlcOakland · $500K – $1.5M
iSelect FundSt. Louis · $250K – $2M
Cultivation CapitalreportedSt. Louis · $100K – $3.5M
Reported raises · per SEC filings
Form D private placements$24.3M disclosed across 2 of 3 rounds · 2019–2023
▶$17.6MraisedJun 2023 · 12 investors · BiotechnologyRule 506(b)
▶$17.6MraisedJun 2023 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Gerald SteinerDirector
- Charles LinDirector
- Elizabeth GallegosExecutive Officer, Director
- Neal GuttersonDirector
- Clay MitchellDirector
- Barry GoldmanExecutive Officer, Director
- Michael GillespieDirector
- Offering amount
- $17.6M
- Amount sold
- $17.6M
- Minimum investment
- $75K
- First sale
- Feb 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$6.7MraisedOct 2021 · 38 investors · BiotechnologyRule 506(b)
▶$6.7MraisedOct 2021 · 38 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Charles WalchExecutive Officer
- Glendon SchusterDirector
- Barry GoldmanExecutive Officer, Director
- Steven SlaterExecutive Officer, Director
- Clay MitchellDirector
- Wesley SelkeDirector
- Offering amount
- $6.7M
- Amount sold
- $6.7M
- Minimum investment
- $10.3K
- First sale
- Sep 2021
- Incorporated
- Corporation, Missouri, 2017
- Federal exemptions
- 06b
▶$1MofferedJan 2019 · BiotechnologyRule 506(c)
▶$1MofferedJan 2019 · Biotechnology
Rule 506(c)Officers, directors & promoters on the filing
- Charlie WalchExecutive Officer, Director
- Barry GoldmanExecutive Officer, Director
- Glendon SchusterDirector
- Offering amount
- $1M
- Minimum investment
- $30K
- Proceeds to insiders
- $120K
- Incorporated
- Limited Liability Company, Missouri, 2017
- Federal exemptions
- 06c
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Competitors · 7
by search overlap
Pivot Bio9 shared keywordsPivot Bio develops agricultural innovations focused on transforming farming practices through microbiology and genetics. The company serves farmers worldwide.
Concertobio7 shared keywordsConcerto develops microbial technologies inspired by microbial ecology, aiming to create products that protect human health, food, and the environment. The company focuses on discovery science to access these microbe-based products.
Octant Bio5 shared keywordsOctant is a therapeutics company that develops small molecule drugs to treat protein misfolding diseases. Using synthetic biology, high-throughput chemistry, and AI/ML, the company's Navigator platform studies how target proteins interact within living human cells to enable drug discovery for rare diseases and oncology.
Anto Biosciences5 shared keywordsAnto is an AI research lab developing foundation models for microbial communities to enable precision medicine by computationally modeling how the microbiome affects individual drug response. The company serves pharmaceutical and clinical research by combining AI with genomic and microbiome data.
Intuitive Biosciences5 shared keywordsIntuitive Bio develops immunoassays and diagnostic products and services, including non-human primate viral and TB tests and test processing, for research laboratories. The company offers assay development from proof of concept to fully-validated assays in a multiplex format supporting 1–100 markers per well.
Pluto4 shared keywordsPluto is a cloud-based life sciences platform for storing, searching, analyzing, and visualizing complex biological data and running bioinformatics pipelines without coding or managing infrastructure. It serves R&D scientists, team leads, and program managers at life science organizations, and offers a Scientific Insights team for custom bioinformatics analyses.
Ditto Biosciences4 shared keywordsDitto Bio uses AI to identify protein candidates from parasites and pathogens for treating autoimmune diseases. The company mines natural compounds from viruses, ticks, and worms whose immune-modulating properties have evolved over millions of years.
Companies competing with Pluton Biosciences for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Pluton Biosciences do?
- Pluton Biosciences develops novel microbes and scales them to industrial volumes at commodity pricing for agriculture and climate applications. The company applies microbial discovery and genomics to create products aimed at sustainable agriculture and environmental protection.
- Who founded Pluton Biosciences?
- Pluton Biosciences was founded by Barry Goldman.
- Who are Pluton Biosciences's investors?
- Pluton Biosciences's investors include First In Ventures, Illumina Ventures, Radicle Growth, Better Ventures, Fall Line Capital, Grantham Foundation, RA Capital, The Yield Lab and 3 more.
- How much funding has Pluton Biosciences raised?
- Pluton Biosciences has disclosed $24.3M raised across 2 of its 3 known rounds.
- Where is Pluton Biosciences headquartered?
- Pluton Biosciences is headquartered in St. Louis, US.